Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Building the Hybrid Cloud
- Connected Government: How to Build and Procure Network Services for the Future
- Continuing Diagnostics and Mitigation: Discussion of Progress and Next Steps
- Federal Executive Forum
- Federal Tech Talk
- The Intersection: Where Technology Meets Transformation
- Maximizing ROI Through Data Center Consolidation
- Moving to the Cloud. What's the best approach for me
- Navigating Tough Choices in Government Cloud Computing
- The New Generation of Database
- Satellite Communications: Acquiring SATCOM in Tight Times
- Targeting Advanced Threats: Proven Methods from Detection through Remediation
- Transformative Technology: Desktop Virtualization in Government
- The Truth About IT Opex and Software Defined Networking
- Value of Health IT
Shows & Panels
Triaminic and Theraflu bottles recalled
Thursday - 1/31/2013, 3:22pm EST
NEW YORK (AP) - Some bottles of Triaminic and Theraflu cold and allergy syrups are being recalled because the child-resistant bottle caps may be defective.
The recall covers 142 production lots of Triaminic syrups and 41 lots of Theraflu syrups. Novartis, which produces the medicines, says the defect could allow for the removal the cap without breaking the seal on the bottle. The company says it received four reports of adverse events related to the Triaminic products.
The products were made between May 2010 and December 2011 at a Novartis facility in Nebraska. Novartis shut down that plant in December 2011 after federal inspections found numerous quality-control problems.
Novartis says it believes 97 percent of the inventory has been used, returned, or quarantined.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)